Cover Image
市場調查報告書

前列腺表皮內腫瘤:全球臨床實驗趨勢

Prostatic Intraepithelial Neoplasia Global Clinical Trials Review, H2, 2016

出版商 GlobalData 商品編碼 300503
出版日期 內容資訊 英文 36 Pages
訂單完成後即時交付
價格
Back to Top
前列腺表皮內腫瘤:全球臨床實驗趨勢 Prostatic Intraepithelial Neoplasia Global Clinical Trials Review, H2, 2016
出版日期: 2016年08月30日 內容資訊: 英文 36 Pages
簡介

本報告提供前列腺表皮內腫瘤相關之臨床研究最新趨勢分析,提供您疾病·治療方法概要,及主要已開發國家的臨床實驗狀況,各地區、各階段的進行狀況,有潛力的贊助商,各企業及研究機關的研究進行狀況,有潛力的藥劑比較等資訊。

本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 歐洲主要國家的臨床實驗數量
    • 北美主要國家的臨床實驗數量
    • 中南美主要國家的臨床實驗數量

G7各國臨床實驗數量:癌症治療藥臨床實驗上前列腺表皮內腫瘤的比例

G7各國的各階段臨床實驗數量

G7各國臨床實驗數量:各進展狀況

E7各國臨床實驗數量:癌症治療藥臨床實驗上前列腺表皮內腫瘤的比例

各階段臨床實驗數量

各進展狀況臨床實驗數量

臨床實驗的目標達成情形

一定期間所採用的實驗對象

贊助商類別的臨床實驗數量

有潛力的贊助商

前列腺表皮內腫瘤治療藥臨床實驗參與的主要企業

臨床實驗簡介概要

附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDHC3737CTIDB

GlobalData's clinical trial report, "Prostatic Intraepithelial Neoplasia Global Clinical Trials Review, H2, 2016" provides an overview of Prostatic Intraepithelial Neoplasia clinical trials scenario. This report provides top line data relating to the clinical trials on Prostatic Intraepithelial Neoplasia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Prostatic Intraepithelial Neoplasia to Oncology Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Prostatic Intraepithelial Neoplasia to Oncology Clinical Trials
  • Clinical Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Prostatic Intraepithelial Neoplasia Therapeutics Clinical Trials
  • Clinical Trial Profile Snapshots
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Prostatic Intraepithelial Neoplasia Therapeutics, Global, Clinical Trials by Region, 2016*
  • Prostatic Intraepithelial Neoplasia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016*
  • Prostatic Intraepithelial Neoplasia Therapeutics Clinical Trials, Europe, Top Countries, 2016*
  • Prostatic Intraepithelial Neoplasia Therapeutics Clinical Trials, North America, Top Countries, 2016*
  • Prostatic Intraepithelial Neoplasia Therapeutics Clinical Trials, Central and South America, Top Countries, 2016*
  • Proportion of Prostatic Intraepithelial Neoplasia to Oncology Clinical Trials, G7 Countries (%), 2016*
  • Prostatic Intraepithelial Neoplasia Therapeutics, G7 Countries, Clinical Trials by Phase, 2016*
  • Prostatic Intraepithelial Neoplasia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016*
  • Proportion of Prostatic Intraepithelial Neoplasia to Oncology Clinical Trials, E7 Countries (%), 2016*
  • Prostatic Intraepithelial Neoplasia Therapeutics, Global, Clinical Trials by Phase, 2016*
  • Prostatic Intraepithelial Neoplasia Therapeutics, Global, Clinical Trials by Trial Status, 2016*
  • Prostatic Intraepithelial Neoplasia Therapeutics Clinical Trials, Global, by End Point Status, 2016*
  • Prostatic Intraepithelial Neoplasia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015
  • Prostatic Intraepithelial Neoplasia Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016*
  • Prostatic Intraepithelial Neoplasia Therapeutics Clinical Trials, Global, Key Sponsors, 2016*
  • Prostatic Intraepithelial Neoplasia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016*

List of Figures

  • Prostatic Intraepithelial Neoplasia Therapeutics, Global, Clinical Trials by Region (%), 2016*
  • Prostatic Intraepithelial Neoplasia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016*
  • Prostatic Intraepithelial Neoplasia Therapeutics Clinical Trials, Europe, Top Countries (%), 2016*
  • Prostatic Intraepithelial Neoplasia Therapeutics Clinical Trials, North America, Top Countries (%), 2016*
  • Proportion of Prostatic Intraepithelial Neoplasia to Oncology Clinical Trials, G7 Countries (%), 2016*
  • Prostatic Intraepithelial Neoplasia Therapeutics, G7 Countries, Clinical Trials by Phase, 2016*
  • Prostatic Intraepithelial Neoplasia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016*
  • Proportion of Prostatic Intraepithelial Neoplasia to Oncology Clinical Trials, E7 Countries (%), 2016*
  • Prostatic Intraepithelial Neoplasia Therapeutics, Global, Clinical Trials by Phase (%), 2016*
  • Prostatic Intraepithelial Neoplasia Therapeutics, Global, Clinical Trials by Trial Status, 2016*
  • Prostatic Intraepithelial Neoplasia Therapeutics Clinical Trials, Global, by End Point Status, 2016*
  • Prostatic Intraepithelial Neoplasia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015
  • Prostatic Intraepithelial Neoplasia Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016*
  • Prostatic Intraepithelial Neoplasia Therapeutics Clinical Trials, Global, Key Sponsors, 2016*
  • Prostatic Intraepithelial Neoplasia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016*
  • GlobalData Methodology
Back to Top